Researchers tout PET/MRI for cancer imaging

09/18/2013 | (free registration)

U.S. and Italian researchers who studied 134 patients found that FDG-PET/MRI was more precise than FDG-PET/CT in assessing lymphadenopathy and certain tumors and proved to be more sensitive to hepatic and bony metastases. PET/MRI also tended to yield treatment-altering data, with seven patients beginning chemotherapy, five undergoing surgery and six avoiding biopsy, researchers reported in a radiology journal.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX